HPV Primary Cervical Screening Laboratory Service in the South West

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-h6vhtk-068139-2026-04-27T11:09:52+01:00",
    "date": "2026-04-27T11:09:52+01:00",
    "ocid": "ocds-h6vhtk-068139",
    "description": "The decision to award this contract in line with Direct Award Process C was based on assessment against the basic selection criteria, which were assessed on a \"Pass\" / \"Fail\" basis, and the 5 key criteria, which were assessed on an \"Assured\" / \"Not Assured\" basis. Multiple assessment areas were included under each of the key criteria and the provider's performance against the current contract, as well as their likely performance against the new contract was assessed. Due to the nature of the assessment and the assessment methodology applied, each key criteria was deemed of equal importance and individual weightings were not applied. Evidence was gathered against the basic selection criteria and each of the key criteria using information available through the existing contract/contract management, published sources and information requests sent to the provider. An assessment panel was then convened to review the evidence gathered for each element of the assessment and agree an assessment score for each criteria, using the relevant assessment matrix. The provider scored a \"pass\" on all elements of the BSC and 'assured' on all elements of the key criteria assessment, therefore meeting requirements of the assessment. Award decisions have been recommended by the Direct Award Process C Assessment Panel, of which the NHS England South West's Public Health Senior Commissioning Manager was a member. Award decisions have been made by the NHS England South West Direct Commissioning Business Cases Panel. There are no identified conflicts of interest. This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 and The Procurement Act 2023 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to decision makers by midnight on 24th April 2026. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR. Written representations should be sent to scwcsu.procurement@nhs.net.",
    "initiationType": "tender",
    "tender": {
        "id": "WA18261",
        "legalBasis": {
            "id": "32014L0024",
            "scheme": "CELEX"
        },
        "title": "HPV Primary Cervical Screening Laboratory Service in the South West",
        "status": "complete",
        "classification": {
            "scheme": "CPV",
            "id": "85145000",
            "description": "Services provided by medical laboratories"
        },
        "mainProcurementCategory": "services",
        "description": "NHS England South West are looking to award a new contract for the provision of a HPV Primary Cervical Screening Laboratory Service to the existing provider, North Bristol NHS Trust. The existing contract for the provision of a HPV Primary Cervical Screening Laboratory services in the South West is due to expire on 30th June 2026 and NHS England South West have proposed that a new contract should replace the existing contract at the end of its term. All requirements outlined in Regulation 6(5) of the Health Care Services (Provider Selection Regime) Regulations 2023 have been met, including not breaching the considerable change threshold, and therefore direct award process C has been deemed the appropriate provider selection process. After conducting an assessment, taking into account the key criteria and applying the basic selection criteria, NHS England South West is content that the existing provider is satisfying the original contract and will likely satisfy the proposed contract to a sufficient standard. The service is anticipated to commence on the 1st July 2026 for an initial contract duration of 21 months, with an option to extend for a further 1 year. The total contract lifecycle value is PS13,905,000 over the initial 21 months, and a maximum possible contract value of PS19,677,000 including extensions. This notice serves as an intention to award the contract to the existing provider under Direct Award Process C of the Provider Selection Regime (PSR).",
        "lots": [
            {
                "id": "1",
                "description": "NHS England South West are looking to award a new contract for the provision of a HPV Primary Cervical Screening Laboratory Service to the existing provider, North Bristol NHS Trust. The cervical screening laboratory is an essential component of the cervical screening programme pathway. The primary purpose of the cervical laboratory is to: * receive and process samples taken for the purposes of the cervical screening programme in primary care and any other relevant setting across their designated geographies. * send the results to the Cervical Screening Administration Service. * refer women who require treatment to their local colposcopy clinic. In addition, the laboratory has to: * arrange the distribution of sample taking kits to all sample taking locations. * maintain a database of sample takers, ensuring their training is up to date. * distribute sample bags and arrange for samples to be transported to the laboratory - which may be using its own transport service, or by making use of local transport and 'spoke' arrangements in laboratories on multiple other acute sites across large geographical areas. * ensure sample takers have a means of requesting tests electronically - typically a separate system from other 'order comms'. * put in place arrangements to access histology results from associated colposcopy activity. * support multi-disciplinary team meetings in each of the associated gynaecology services in order to arrive at a diagnosis/develop treatment plans. * support invasive cancer audits in each of the associated gynaecology services. * participation in local programme boards to support continuous quality improvement across the whole pathway. * support the training of cyto-histopathologist and other specialist staff across the whole network. This requires the laboratory to be at the heart of a complex network of services and relationships, with data sharing and logistics in place across multiple ICB geographies. The existing contract for the provision of a HPV Primary Cervical Screening Laboratory services in the South West is due to expire on 30th June 2026 and NHS England South West have proposed that a new contract should replace the existing contract at the end of its term. All requirements outlined in Regulation 6(5) of the Health Care Services (Provider Selection Regime) Regulations 2023 have been met, including not breaching the considerable change threshold, and therefore direct award process C has been deemed the appropriate provider selection process. After conducting an assessment, taking into account the key criteria and applying the basic selection criteria, NHS England South West is content that the existing provider is satisfying the original contract and will likely satisfy the proposed contract to a sufficient standard. The service is anticipated to commence on the 1st July 2026 for an initial contract duration of 21 months, with an option to extend for a further 1 year. The total contract lifecycle value is PS13,905,000 over the initial 21 months, and a maximum possible contract value of PS19,677,000 including extensions. The Commissioner will be contracting for the services using the Full-Length NHS Standard Contract. This notice serves as an intention to award the contract to the existing provider under Direct Award Process C of the Provider Selection Regime (PSR). During the life of the proposed new contract, NHS England South West intend to consider a longer term commissioning strategy for the service. This procurement has been carried out by NHS South, Central and West Commissioning Support Unit (SCW) on behalf of the Commissioners.",
                "awardCriteria": {
                    "criteria": [
                        {
                            "name": "The existing provider is satisfying the original contract and will likely satisfy the proposed contract to a sufficient standard",
                            "type": "quality",
                            "description": "100"
                        },
                        {
                            "type": "price",
                            "description": "0"
                        }
                    ]
                },
                "hasOptions": false,
                "status": "cancelled"
            }
        ],
        "items": [
            {
                "id": "1",
                "deliveryAddresses": [
                    {
                        "region": "UKK"
                    }
                ],
                "relatedLot": "1"
            }
        ],
        "procurementMethod": "limited",
        "procurementMethodDetails": "Award procedure without prior publication of a call for competition",
        "procurementMethodRationaleClassifications": [
            {
                "id": "D_OUTSIDE_SCOPE",
                "scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL",
                "description": "The procurement falls outside the scope of application of the directive"
            }
        ],
        "procurementMethodRationale": "This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to the relevant authority by midnight on 24th April 2026. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.",
        "amendments": [
            {
                "id": "1",
                "description": "Contract award took place on 27th April 2026 following conclusion of the standstill period. The service is anticipated to commence on the 1st July 2026 for an initial contract duration of 21 months, with an option to extend for a further 1 year. The total contract lifecycle value is PS13,905,000 over the initial 21 months, and a maximum possible contract value of PS19,677,000 including extensions. This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 and The Procurement Act 2023 do not apply to this award. This contract has now been formally awarded using direct award process C."
            }
        ]
    },
    "awards": [
        {
            "id": "033379-2026-1",
            "relatedLots": [
                "1"
            ],
            "status": "active",
            "suppliers": [
                {
                    "id": "GB-FTS-12898",
                    "name": "North Bristol NHS Trust"
                }
            ]
        }
    ],
    "parties": [
        {
            "id": "GB-FTS-131556",
            "name": "NHS England South West",
            "identifier": {
                "legalName": "NHS England South West",
                "noIdentifierRationale": "notOnAnyRegister"
            },
            "address": {
                "locality": "Taunton",
                "region": "UKK",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "email": "scwcsu.procurement@nhs.net"
            },
            "roles": [
                "buyer"
            ],
            "details": {
                "url": "https://www.england.nhs.uk/south/",
                "classifications": [
                    {
                        "id": "BODY_PUBLIC",
                        "scheme": "TED_CA_TYPE",
                        "description": "Body governed by public law"
                    },
                    {
                        "id": "07",
                        "scheme": "COFOG",
                        "description": "Health"
                    }
                ]
            }
        },
        {
            "id": "GB-FTS-12898",
            "name": "North Bristol NHS Trust",
            "identifier": {
                "legalName": "North Bristol NHS Trust",
                "noIdentifierRationale": "notOnAnyRegister"
            },
            "address": {
                "locality": "Bristol",
                "region": "UKK11",
                "countryName": "United Kingdom"
            },
            "roles": [
                "supplier"
            ],
            "details": {
                "scale": "large"
            }
        }
    ],
    "buyer": {
        "id": "GB-FTS-131556",
        "name": "NHS England South West"
    },
    "contracts": [
        {
            "id": "033379-2026-1",
            "awardID": "033379-2026-1",
            "status": "active",
            "value": {
                "amount": 19677000,
                "currency": "GBP"
            },
            "dateSigned": "2026-04-07T00:00:00+01:00"
        }
    ],
    "bids": {
        "statistics": [
            {
                "id": "1",
                "measure": "bids",
                "relatedLot": "1",
                "value": 1
            }
        ]
    },
    "language": "en"
}